Michael Arenberg
Chief Operating Officer at IMAGO BIOSCIENCES, INC.
Michael Arenberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Chief Operating Officer | 22/03/2022 | - |
Career history of Michael Arenberg
Former positions of Michael Arenberg
| Companies | Position | Start | End |
|---|---|---|---|
| DURECT CORPORATION | Director of Finance/CFO | 14/10/2018 | 16/03/2022 |
| Investor Relations Contact | 31/12/1998 | 16/03/2022 | |
| Corporate Officer/Principal | 16/07/2009 | 14/10/2018 | |
| Corporate Secretary | - | 16/03/2022 | |
IntraEAR, Inc.
 IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Founder | 31/12/1995 | 31/12/1998 |
| Sales & Marketing | 31/12/1995 | 31/12/1998 |
Training of Michael Arenberg
| University of Denver | Graduate Degree |
| Leavey School of Business | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Michael Arenberg
- Experience
